Major Depressive Disorder (MDD) is far from a cookie-cutter diagnosis. Different patients report suffering from different subsets of symptoms, yet most are ultimately prescribed the same first-line treatments – typically selective serotonin reuptake inhibitors (SSRIs)- regardless of their individual experience.
New fMRI neurofeedback study trains the brain to reduce depressive rumination
- Post author:admin
- Post published:May 13, 2026
- Post category:uncategorized